Ongoing research and sustained efforts are creating optimism for more effective therapies and the possibility of a cure.
Cardiovascular disease is a silent killer and a worldwide threat. According to the World Health Organization, 17-18 million ...
On 15 September 2025, Regeneron Pharmaceuticals conducted a study is researching an experimental drug called REGN5381 (called ...
The European Society of Cardiology has recently published guidelines regarding the management of pericarditis and myocarditis.
Background Postoperative cerebral infarction following coronary artery bypass grafting (CABG) for multivessel coronary artery ...
Cardiac rehabilitation is a crucial, underutilized service for heart attack survivors, offering structured exercise programs ...
ASX healthcare sector struggling to find relief after weeks of weakness but Morgans’ Scott Power reckons it might finally be ...
During sleep, the body completes a number of essential actions necessary to maintain optimal health and function. However, ...
September 29 is World Heart Day, which was established by the World Heart Federation (WHF) to raise awareness about heart ...
GMA Network on MSN
DOF explains factors for returning PhilHealth’s P60-B excess fund
The Department of Finance (DOF) on Saturday welcomed President Ferdinand “Bongbong” Marcos Jr.’s decision to restore the P60 ...
The Department of Finance (DOF) has voiced support for President Ferdinand R. Marcos Jr.'s decision to restore P60 billion in ...
The Company has submitted a supplemental New Drug Application (sNDA) seeking the approval of revumenib for the treatment of R/R mNPM1 AML. The sNDA has been granted Priority Review by the FDA and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback